Analysts from Cowen, an investment bank and financial services company, surveyed 26 hospitals, pharmacy benefit managers and health maintenance organizations that bought more than $52 billion in drugs in 2018.
The 7 percent average annual increase is up slightly from a year ago, according to STAT. Of those surveyed, 38 percent said they think at least three-quarters of the price hikes will be thanks to a shift to using newer, higher-priced drugs.
The government likely won’t implement price controls on prescription drugs in the next three years, thanks to the uncertainty of the 2020 presidential election and disagreements between Republicans and Democrats on how to bring down drug costs, STAT reported.
Read the full article here.
More articles on pharmacy:
Drug shortages update: 5 things to know
Grocery store pharmacies across the country finding it harder to stay in business
AbbVie to donate $1M of drug China says will combat coronavirus
